AstraZeneca Pharma India Limited
NSE:ASTRAZEN.NS
7306.8 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||||
Current Assets: | |||||||||||||||||||
Cash & Cash Equivalents
| 5,058.423 | 5,003.374 | 4,484.2 | 3,523.4 | 835 | 1,732.4 | 1,139.8 | 13.164 | 62.006 | 14.386 | 46.77 | 4.621 | 536.507 | 853.902 | 682.354 | 1,438.039 | 1,110.355 | 1,080.005 | 671.461 |
Short Term Investments
| 181.508 | 107.171 | 123.102 | 56.56 | 1,690 | 0 | 116.8 | 1,132.3 | 700 | 225 | 830 | 165.019 | 0 | 0 | 0 | 0 | 0 | 152.119 | 165.161 |
Cash and Short Term Investments
| 5,058.423 | 5,110.545 | 4,484.2 | 3,523.4 | 2,525 | 1,732.4 | 1,256.6 | 1,145.464 | 762.006 | 239.386 | 876.77 | 169.64 | 536.507 | 853.902 | 682.354 | 1,438.039 | 1,110.355 | 1,232.124 | 836.622 |
Net Receivables
| 1,532.519 | 1,076.03 | 982.851 | 912.165 | 956 | 912.1 | 641.1 | 796.139 | 1,139.05 | 1,522.242 | 876.107 | 610.05 | 323.079 | 437.142 | 682.061 | 501.362 | 470.719 | 446.762 | 309.851 |
Inventory
| 2,278.82 | 1,902.141 | 1,402.2 | 1,598 | 1,651.5 | 1,181 | 1,131.5 | 577.177 | 767.296 | 861.307 | 957.576 | 853.691 | 750.969 | 572.026 | 352.001 | 340.064 | 237.879 | 340.136 | 251.22 |
Other Current Assets
| 457.292 | 266.175 | 187.449 | 154.035 | 290.7 | 221.7 | 180 | 8.91 | 14.49 | 9.67 | 15.908 | 14.725 | 365.052 | 332.432 | 289.357 | 275.068 | 293.553 | 36.847 | 32.286 |
Total Current Assets
| 9,327.054 | 8,354.891 | 7,056.7 | 6,187.6 | 5,423.2 | 4,047.2 | 3,209.2 | 2,527.69 | 2,682.841 | 2,632.605 | 2,726.361 | 1,648.106 | 1,975.607 | 2,195.501 | 2,005.773 | 2,554.534 | 2,112.505 | 2,055.869 | 1,429.979 |
Non-Current Assets: | |||||||||||||||||||
Property, Plant & Equipment, Net
| 648.42 | 701.94 | 766.9 | 849.8 | 960.1 | 835.7 | 800 | 916.488 | 1,036.682 | 1,131.941 | 1,035.309 | 982.415 | 901.824 | 513.877 | 273.368 | 292.122 | 302.27 | 302.699 | 312.155 |
Goodwill
| 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 21.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.068 | 30.068 | 30.068 | 30.068 | 0 |
Goodwill and Intangible Assets
| 21.105 | 76.219 | 0 | -43.3 | -39 | -28.6 | -2.5 | -441.3 | 0 | 0 | 0 | 0 | 0 | 0 | 30.068 | 30.068 | 30.068 | 30.068 | 0 |
Long Term Investments
| 27.414 | -76.219 | -93.8 | 43.3 | 39 | 28.6 | 2.5 | 5.7 | -699.995 | -224.995 | -829.995 | -164.962 | 0 | 0 | 0 | 0.057 | 0 | -152.053 | -165.039 |
Tax Assets
| 212.491 | 205.679 | 163 | 145.3 | 146.4 | 233.6 | 325.5 | 435.6 | 0 | 0 | 0 | 0 | 177.623 | 75.419 | 29.4 | 23.712 | 17.263 | 9.812 | 12.241 |
Other Non-Current Assets
| 543.799 | 586.342 | 672.8 | 564.4 | 533.9 | 501.5 | 270.7 | 333.27 | 1,037.682 | 576.377 | 1,224.2 | 595.458 | 365.789 | 302.022 | 0.057 | -17.687 | 0.066 | 152.119 | 165.161 |
Total Non-Current Assets
| 1,453.229 | 1,493.961 | 1,508.9 | 1,559.5 | 1,640.4 | 1,570.8 | 1,396.2 | 1,249.758 | 1,374.37 | 1,483.323 | 1,429.514 | 1,412.91 | 1,445.235 | 891.318 | 332.893 | 328.272 | 349.668 | 342.645 | 324.519 |
Total Assets
| 10,780.283 | 9,848.852 | 8,565.6 | 7,747.1 | 7,063.6 | 5,618 | 4,605.4 | 3,777.448 | 4,057.211 | 4,115.928 | 4,155.875 | 3,061.017 | 3,420.842 | 3,086.82 | 2,338.666 | 2,882.806 | 2,462.173 | 2,398.514 | 1,754.498 |
Liabilities & Equity: | |||||||||||||||||||
Current Liabilities: | |||||||||||||||||||
Account Payables
| 1,965.057 | 2,278.766 | 1,880.6 | 1,783.7 | 2,097.2 | 1,682 | 953.4 | 357.704 | 946.284 | 1,112.716 | 1,098.71 | 906.722 | 177.654 | 143.758 | 402.773 | 0.024 | 41.225 | 1.896 | 2.051 |
Short Term Debt
| 18.146 | 35.225 | 36.1 | 35.1 | 25.4 | 0 | -16 | -96.8 | -87.498 | 2.752 | 2.752 | 2.913 | 0 | 0 | 9.86 | 9.86 | 9.86 | 9.86 | 9.86 |
Tax Payables
| 66.61 | 24.229 | 49.4 | 56.3 | 21 | 18.3 | 53.6 | 53.9 | 78.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 66.61 | 401.7 | 306.9 | 1,079.7 | 1,026.4 | 0 | 16 | 96.8 | 87.498 | 1,418.663 | 1,279.384 | 1,091.858 | 0 | 0 | 431.498 | 748.982 | 540.271 | 760.112 | 272.909 |
Other Current Liabilities
| 1,521.364 | 1,123.725 | 1,102.9 | 136.5 | 123.4 | 907.8 | 1,116.1 | 1,490.977 | 1,538.114 | 64.055 | 54.185 | 57.102 | 1,344.893 | 1,109.931 | 49.353 | 337.442 | 277.722 | 209.405 | 197.724 |
Total Current Liabilities
| 3,571.177 | 3,839.416 | 3,326.5 | 3,035 | 3,272.4 | 2,589.8 | 2,069.5 | 1,848.68 | 2,484.398 | 2,598.185 | 2,435.031 | 2,058.594 | 1,522.546 | 1,253.689 | 893.484 | 1,096.308 | 869.078 | 981.273 | 482.544 |
Non-Current Liabilities: | |||||||||||||||||||
Long Term Debt
| 27.836 | 36.911 | 50.2 | 86.3 | 93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 625 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| -10.6 | -15.3 | -18.7 | -27.8 | -28.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 10.6 | 15.3 | 18.7 | 27.8 | 28.3 | 10.6 | 17.7 | 33.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 62.096 | 85.642 | 75 | 64.1 | 53.8 | 9.6 | 48.9 | 90.802 | 12.669 | 10.189 | 4.894 | 4.894 | 5.444 | 36.235 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 89.932 | 122.553 | 125.2 | 150.4 | 146.8 | 20.2 | 66.6 | 124.202 | 12.669 | 10.189 | 4.894 | 4.894 | 5.444 | 36.235 | 0 | 625 | 0 | 0 | 0 |
Total Liabilities
| 3,661.109 | 3,961.969 | 3,451.7 | 3,185.4 | 3,419.2 | 2,610 | 2,136.1 | 1,972.882 | 2,497.068 | 2,608.375 | 2,439.924 | 2,063.487 | 1,527.99 | 1,289.924 | 893.484 | 1,721.308 | 869.078 | 981.273 | 482.544 |
Equity: | |||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
Retained Earnings
| 5,781.5 | 4,556.4 | 3,789.6 | 3,241 | 2,323.7 | 1,682.2 | 1,143.7 | 499.747 | 255.325 | 202.735 | 411.132 | 416.221 | 1,842.852 | 1,746.896 | 1,395.182 | 1,111.497 | 1,543.096 | 1,367.241 | 1,221.954 |
Accumulated Other Comprehensive Income/Loss
| 564.2 | 557 | 550.8 | 547.2 | 1,270.7 | -472.4 | -303.9 | -1,156.448 | -1,033.969 | -874.501 | -725.208 | -710.986 | -607.212 | -540.556 | -527.857 | -507.014 | -497.551 | -460.773 | -430.763 |
Other Total Stockholders Equity
| 723.474 | 723.483 | 723.5 | 723.5 | 0 | 1,748.2 | 1,579.5 | 2,411.266 | 2,288.787 | 2,129.319 | 1,980.027 | 1,242.294 | 607.212 | 540.556 | 527.857 | 507.014 | 497.551 | 460.773 | 430.763 |
Total Shareholders Equity
| 7,119.174 | 5,886.883 | 5,113.9 | 4,561.7 | 3,644.4 | 3,008 | 2,469.3 | 1,804.566 | 1,560.143 | 1,507.553 | 1,715.95 | 997.529 | 1,892.852 | 1,796.896 | 1,445.182 | 1,161.497 | 1,593.096 | 1,417.241 | 1,271.954 |
Total Equity
| 7,119.174 | 5,886.883 | 5,113.9 | 4,561.7 | 3,644.4 | 3,008 | 2,469.3 | 1,804.566 | 1,560.143 | 1,507.553 | 1,715.95 | 997.529 | 1,892.852 | 1,796.896 | 1,445.182 | 1,161.497 | 1,593.096 | 1,417.241 | 1,271.954 |
Total Liabilities & Shareholders Equity
| 10,780.283 | 9,848.852 | 8,565.6 | 7,747.1 | 7,063.6 | 5,618 | 4,605.4 | 3,777.448 | 4,057.211 | 4,115.928 | 4,155.875 | 3,061.017 | 3,420.842 | 3,086.82 | 2,338.666 | 2,882.806 | 2,462.173 | 2,398.514 | 1,754.498 |